Isolation and infectious diseases policy - Hampshire Hospitals NHS ...

Winchester & Eastleigh Healthcare NHS Trust
Policy for Isolation and Infectious Diseases Policy
Varicella zoster
Parvovirus B19(particularly antenatal wards and paediatrics)
Norovirus
Fungi – in specialist units (like ITU, NNU)
Candida species
Aspergilus
There are separate mechanisms for notifying and responding to cases of healthcare
associated infections, Human Immunodeficiency Virus (HIV)/Sexually Transmitted
Infections (STIs) and Creutzfeldt-Jakob Disease. Therefore, cases of these diseases
should not be reported routinely under this requirement.
Healthcare associated infections: Mandatory reporting of healthcare associated
infections has proved to be effective in providing real time surveillance data that infection
control teams routinely use for control measures. Such surveillance systems include all
laboratory reports of bacteraemia for a variety of microorganisms, some of which are
associated with healthcare settings; Staphylococcus aureus (including MRSA);
Clostridium difficile; Surgical Site Infection Surveillance Service (SSISS); and
glycopeptide-resistant enterococcal bacteraemia. See CPO21 Surveillance Policy.
HIV and STIs: Genitourinary medicine (GUM)/sexual health clinics routinely follow up
contacts of cases and take necessary public health actions. Clusters or outbreaks of
disease are managed in collaboration with the HPA. Patient confidentiality is of vital
importance in HIV and STI settings to retain patients’ trust in health services and to
encourage access to clinics and services for information and advice, testing, diagnosis
and treatment. However, notification is required if a patient attending a GUM clinic is
diagnosed with acute infectious hepatitis. This disease is also spread by non-sexual
means and so notification will ensure that contact tracing is undertaken and control
measures offered to non-sexual contacts that could be at risk.
CJD: The incidence of Creutzfeldt-Jakob Disease is monitored in the UK by the National
CJD Surveillance Unit (NCJDSU) and all suspected cases should be reported to this
unit. The unit assists clinicians with the investigation of this disease and works in
collaboration with the HPA and the CJD Incidents Panel in the investigation and
management of CJD incidents. See CPr031 CJD and other Transmissible Spongiform
Encephalopathy Guidelines.
24
Authorities
Document Control Information
Author:
Sponsor:
Date:
Dr Kordo Saeed
microbiologist
Sue Dailly Lead Nurse
Infection Prevention and
Control
Paula Shobbrook Director of
Infection Prevention and
Control
01/08/11
Type:
Scope:
Reference:
Issue No:
Status:
Policy
Major
CP022 (IC 04)
4
Published